Follow
Anette Mullertz
Anette Mullertz
Bioneer:FARMA, Department of Pharmacy, University of Copenhagen
Verified email at sund.ku.dk
Title
Cited by
Cited by
Year
In vitro models for the prediction of in vivo performance of oral dosage forms
ES Kostewicz, B Abrahamsson, M Brewster, J Brouwers, J Butler, ...
European Journal of Pharmaceutical Sciences 57, 342-366, 2014
4032014
A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium
NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard
European Journal of Pharmaceutical Sciences 14 (2), 115-122, 2001
3542001
Lipid-based formulations for oral administration of poorly water-soluble drugs
H Mu, R Holm, A Müllertz
International journal of pharmaceutics 453 (1), 215-224, 2013
3442013
New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs
A Müllertz, A Ogbonna, S Ren, T Rades
Journal of pharmacy and pharmacology 62 (11), 1622-1636, 2010
3412010
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
2962019
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
R Hayeshi, C Hilgendorf, P Artursson, P Augustijns, B Brodin, ...
European Journal of Pharmaceutical Sciences 35 (5), 383-396, 2008
2932008
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs
CAS Bergström, R Holm, SA Jørgensen, SBE Andersson, P Artursson, ...
European Journal of Pharmaceutical Sciences 57, 173-199, 2014
2832014
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a …
HD Williams, P Sassene, K Kleberg, JC Bakala-N'Goma, M Calderone, ...
Journal of pharmaceutical sciences 101 (9), 3360-3380, 2012
2692012
A dynamic in vitro lipolysis model: II: Evaluation of the model
NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard
European Journal of Pharmaceutical Sciences 14 (3), 237-244, 2001
2562001
Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium-and long-chain triacylglycerols
JØ Christensen, K Schultz, B Mollgaard, HG Kristensen, A Mullertz
European Journal of Pharmaceutical Sciences 23 (3), 287-296, 2004
2372004
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
N Thomas, R Holm, A Müllertz, T Rades
Journal of controlled release 160 (1), 25-32, 2012
2282012
Bile salts and their importance for drug absorption
R Holm, A Müllertz, H Mu
International Journal of Pharmaceutics 453 (1), 44-55, 2013
2192013
Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems …
R Holm, CJH Porter, GA Edwards, A Müllertz, HG Kristensen, ...
European journal of pharmaceutical sciences 20 (1), 91-97, 2003
2122003
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media
VH Sunesen, BL Pedersen, HG Kristensen, A Müllertz
European journal of pharmaceutical sciences 24 (4), 305-313, 2005
2022005
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
C Stillhart, K Vuèiæeviæ, P Augustijns, AW Basit, H Batchelor, TR Flanagan, ...
European Journal of Pharmaceutical Sciences 147, 105280, 2020
1852020
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state
FS Nielsen, KB Petersen, A Müllertz
European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 553-562, 2008
1812008
Bioavailability of seocalcitol: II: Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long …
M Grove, A Müllertz, JL Nielsen, GP Pedersen
European journal of pharmaceutical sciences 28 (3), 233-242, 2006
1762006
In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems
AT Larsen, P Sassene, A Müllertz
International journal of pharmaceutics 417 (1-2), 245-255, 2011
1682011
A comparison of the solubility of danazol in human and simulated gastrointestinal fluids
BL Pedersen, A Mullertz, H Brondsted, HG Kristensen
Pharmaceutical research 17 (7), 891, 2000
1672000
Morphological observations on a lipid-based drug delivery system during in vitro digestion
DG Fatouros, B Bergenstahl, A Mullertz
European Journal of Pharmaceutical Sciences 31 (2), 85-94, 2007
1642007
The system can't perform the operation now. Try again later.
Articles 1–20